Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA
, Timothy B. Frankland, Yihe G. Daida, Jennifer R. Honda, Kenneth N. Olivier, Adrian Zelazny, Stacey Honda, and D. Rebecca Prevots
Author affiliations: United States Public Health Service, Commissioned Corps, Rockville, Maryland, USA (J. Adjemian); National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA (J. Adjemian, A. Zelazny, D.R. Prevots); Kaiser Permanente, Honolulu, Hawaii, USA (T.B. Frankland, Y.G. Daida, S. Honda); University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA (J.R. Honda); National Jewish Health, Denver, Colorado, USA (J.R. Honda); National Heart, Lung, and Blood Institute, Bethesda (K.N. Olivier)
Figure 2. Annual prevalence of pulmonary nontuberculous mycobacteria isolation, nontuberculous mycobacterial pulmonary disease, and tuberculosis (A) and annual prevalence of pulmonary nontuberculous mycobacteria isolation by species (B) among a cohort of Kaiser Permanente Hawaii patients, Hawaii, 2005–2013. MAC, Mycobacterium avium complex; NTM, nontuberculous mycobacteria; NTMPD, nontuberculous mycobacterial pulmonary disease; TB, tuberculosis.
Page created: February 17, 2017
Page updated: February 17, 2017
Page reviewed: February 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.